Vedolizumab 11532-3002
Product NDC
11532-3002- Manufacturer
- Takeda Pharmaceutical Company Limited
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- May 20, 2014
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vedolizumab | 300 mg/1 |
Packaging Options(1)
400 VIAL in 1 CARTON (11532-3002-1) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL